GDBspace, a Space Pharmaceuticals company, enters into a licensing agreement with Humanwell Healthcare, for the discovery of Covid-19 inhibitors using GDBspace’s chemical space drug discovery engine
GDBspace AG, a company specialized in computational methods for drug discovery, today announced that it entered into a sponsored research agreement with Ruibeixiyu Biotech, for the design of Covid-19 inhibitors for treatment of coronavirus infections.